Francielle Nunes-Graus
Alcantara, RJ 20551030, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model.
Journal: World journal of hepatology
Published: December 11, 2018
The renin-angiotensin system as a target to solve the riddle of endocrine pancreas homeostasis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 26, 2018
GW0742 (PPAR-beta agonist) attenuates hepatic endoplasmic reticulum stress by improving hepatic energy metabolism in high-fat diet fed mice.
Journal: Molecular and cellular endocrinology
Published: December 21, 2017
Differential actions of PPAR-α and PPAR-β/δ on beige adipocyte formation: A study in the subcutaneous white adipose tissue of obese male mice.
Journal: PloS one
Published: September 21, 2017
Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
Journal: Biochimie
Published: April 26, 2017
Differential effects of angiotensin receptor blockers on pancreatic islet remodelling and glucose homeostasis in diet-induced obese mice.
Journal: Molecular and cellular endocrinology
Published: April 11, 2016
Enhanced pan-peroxisome proliferator-activated receptor gene and protein expression in adipose tissue of diet-induced obese mice treated with telmisartan.
Journal: Experimental physiology
Published: October 19, 2014
Pregestational maternal obesity impairs endocrine pancreas in male F1 and F2 progeny.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: April 06, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026